Back to search

Article

The West Africa Lassa fever Consortium pre-positioned protocol for a Phase II/III adaptive, randomised, controlled, platform trial to evaluate multiple Lassa fever therapeutics

2023-06-02

Abstract excerpt

<h4>Background: </h4> : This is a standardized, pre-positioned protocol for the coordinated evaluation of Lassa fever therapeutics. The protocol is the product of discussions that took place in 2021 and 2022 among international investigators from a wide range of scientific and medical disciplines working together within the West Africa Lassa fever Consortium (WALC). <h4>Methods: </h4> : This is a clinical Phase I...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
02ddd740-bfad-5b76-8814-d00ac987a926
DOI
10.12688/wellcomeopenres.19041.2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The West Africa Lassa fever Consortium pre-positioned protocol for a Phase II/III adaptive, randomised, controlled, platform trial to evaluate multiple Lassa fever therapeuticsDOI 10.12688/wellcomeopenres.19041.2
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Semantic proximity
The I-SPY COVID Adaptive Platform Trial for COVID-19 Acute Respiratory Failure: Rationale, Design and OperationsSemantic proximity
Success Rates and Timelines of African-Inclusive Phase III Trials: A Retrospective AnalysisSemantic proximity
Methodological Analysis of Bias Risks in Adaptive Multi-Arm Platform Trials: A Case-Series from Three COVID-19 StudiesSemantic proximity
Success Rates and Timelines of African-Inclusive Phase III Trials: A Retrospective AnalysisSemantic proximity
WHO Fever Management Guidelines: Challenges in Harnessing the Benefits During Covid-19 PandemicSemantic proximity
Determining the return on investment of a global adaptive platform trial for critically ill patients during COVID-19: A value of implementation analysis in low- and middle-income countries and globallySemantic proximity
Determining the return on investment of a global adaptive platform trial for critically ill patients during COVID-19: A value of implementation analysis in low- and middle-income countries and globallySemantic proximity
Enable, Empower, Succeed: Harnessing Open Science for Antimicrobial Resistance ContainmentSemantic proximity
Early suPAR-Guided Anakinra Treatment in COVID-19 Pneumonia: Subgroup Analyses and 90-Day Outcomes of the SAVE-MORE TrialSemantic proximity
TheStaphylococcus aureusNetwork Adaptive Platform Trial Protocol: New Tools for an Old FoeSemantic proximity
Creating equity in health research to drive more and better evidenceSemantic proximity
Select a neighboring publication to make it the new centre.